Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Fennec Pharmaceuticals Inc T.FRX

Alternate Symbol(s):  ADHXD

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:RE:IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?

The obvious solution at this stage is to just sell the darn company (at a discount) to a real pharmaceautical company who  has the capability to complete the process  rate and reply

RE:IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?

Absolute dud    The fact that they failed at the manufacturing revisions shows that they and their mfg partner  are incompetant at this aspect of the process.  Wonder who that is ?...read more

IS THIRD TIME THE CHARM FOR FENNEC PHARMACEUTICALS?

$FENC  Fennec Pharmaceuticals (NASDAQ:FENC), a "specialty pharmaceutical company", received a CRL from the FDA for its New Drug Application (NDA) for PEDMARK™ (sodium...read more

11.50/18.00

Thats a heck of a spread on the bid ask?  Has my machine gone bonkers?  rate and reply

RE:Times a wasting

Resubmission is in!  Is there anyone out there to notice? Guess we still have to hope that they dont fail....with the FDA I am never confident of anything. Buyout coming???  rate and reply

Times a wasting

No news at all.  Wonder whats up with that resubmission? Shouldnt financials be out for this quarter? I thought they were reasonably cashed up but lack of any communication from the company is...read more

RE:Silent board

Not too may shares outstanding + less than avg 100k shares trading in CanadaUS in total = not enough retail owners to light up a Stockhouse board. Yahoo forum has a bit more action. Revenue wise...read more

RE:Silent board

Any idea when FRX will report the first revenue? Just a rough estimate. Thanks.  rate and reply

Silent board

Why is this board so silent? Aren't any retail investors in FRX?  rate and reply
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >